Skip to main content

Table 1 The expression of PKP1/2/3 mRNA in different types of ovarian cancer and normal tissues (Oncomine)

From: Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments

Types of ovarian cancer (cases) vs. normal tissues (cases)

Fold change

t-test

P value

Ref

PKP1

 Ovarian serous cystadenocarcinoma (586) vs. Ovary (8)

1.087

4.984

4.49E−04

TCGA ovarian

 Ovarian clear cell adenocarcinoma (8) vs. Ovary (4)

1.152

3.743

2.00E−03

Hendrix ovarian

 Ovarian mucinous adenocarcinoma (13) vs. Ovary (4)

1.084

3.01

1.10E−02

 

 Ovarian serous adenocarcinoma (41) vs. Ovary (4)

1.054

2.231

4.30E−02

 

 Ovarian serous surface papillary carcinoma (28) vs. Ovary (4)

1.178

1.755

4.50E−02

Welsh ovarian

 Ovarian endometrioid adenocarcinoma (9) vs. Ovarian surface epithelium (5)

1.184

2.182

0.025

Lu ovarian

 Ovarian carcinoma (185) vs. Ovarian surface epithelium (10)

1.28

5.551

7.19E−05

Bonome ovarian

PKP2

 Ovarian serous adenocarcinoma (43) vs. Peritoneum (10)

7.903

8.409

7.48E−07

Yoshihara Ovarian

 Ovarian carcinoma (185) vs. Ovarian surface epithelium (10)

1.157

4.37

4.37E−04

Bonome ovarian

 Ovarian mucinous adenocarcinoma (13) vs. Ovary (4)

1.195

2.126

4.00E−02

Hendrix ovarian

PKP3

 Ovarian serous cystadenocarcinoma (586) vs. Ovary (8)

1.28

2.071

3.70E−02

TCGA ovarian

 Ovarian serous adenocarcinoma (43) vs. Peritoneum (10)

62.784

14.553

2.34E−09

Yoshihara ovarian

 Ovarian carcinoma (185) vs. Ovarian surface epithelium (10)

2.459

11.985

4.35E−09

Bonome ovarian

 Ovarian serous adenocarcinoma (6) vs. Ovary (4)

1.871

5.866

6.07E−04

Adib ovarian

 Ovarian mucinous adenocarcinoma (13) vs. Ovary (4)

1.489

9.539

6.64E−07

Hendrix ovarian

 Ovarian clear cell adenocarcinoma (8) vs. Ovary (4)

1.338

6.555

3.92E−05

 

 Ovarian serous adenocarcinoma (41) vs. Ovary (4)

1.352

8.728

2.92E−05

 

 Ovarian endometrioid adenocarcinoma (37) vs. Ovary (4)

1.318

8.488

1.20E−04

 

 Ovarian clear cell adenocarcinoma (7) vs. Ovarian surface epithelium (5)

1.65

3.636

5.00E−03

Lu ovarian

 Ovarian mucinous adenocarcinoma (9) vs. Ovarian surface epithelium (5)

1.458

2.509

1.80E−02

 

 Ovarian serous adenocarcinoma (20) vs. Ovarian surface epithelium (5)

1.6

3.574

7.00E−03

 

 Ovarian endometrioid adenocarcinoma (9) vs. Ovarian surface epithelium (5)

1.455

2.661

1.70E−02

Â